Archer’s CEO, Dr Simon Ruffell, joined ASX Briefs to share how Archer is bringing quantum computing and biochip technologies to life.
Listen to the full podcast on Spotify
"Quantum computing breakthroughs and revolutionary medical diagnostics might sound like distant future technologies, but Archer Materials is bringing them to life right now. Our fascinating conversation with Dr Simon Ruffell, recently promoted from CTO to CEO, reveals how this Australian semiconductor company is simultaneously advancing two groundbreaking technologies with global implications.
Archer's quantum computing program has reached several crucial technical milestones, including extended spin lifetimes in carbon-based quantum films and successful coupling to superconducting resonators. These achievements might sound complex, but they represent fundamental building blocks toward creating functional qubits - the essential components of quantum computers.
Meanwhile, Archer's biochip program is moving rapidly toward practical applications. Their breakthrough technology can detect potassium levels in blood samples - crucial for monitoring chronic kidney disease. Recent achievements include integrating sophisticated graphene sensors with silicon circuitry and dramatically improving measurement consistency from 15% variability down to just 1.5%. By the end of 2024, they aim to demonstrate a prototype that can analyse blood samples in minutes, transitioning from laboratory demonstrations to tangible, functional hardware.
With $15 million in cash reserves, strong technical progress on both fronts, and a leadership team bringing experience from technology giants like Microsoft and Applied Materials, Archer Materials represents a fascinating intersection of cutting-edge science and commercial potential."
Get the latest updates on our breakthrough technologies and research developments. Join thousands of researchers, investors, and technology enthusiasts.
